{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T17:06:38Z","timestamp":1794416798619,"version":"4.9.1"},"publisher-location":"New York, NY","reference-count":101,"publisher":"Springer US","isbn-type":[{"value":"9781461420972","type":"print"},{"value":"9781461420989","type":"electronic"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012]]},"DOI":"10.1007\/978-1-4614-2098-9_19","type":"book-chapter","created":{"date-parts":[[2012,3,28]],"date-time":"2012-03-28T02:23:26Z","timestamp":1332901406000},"page":"290-313","source":"Crossref","is-referenced-by-count":14,"title":["Advances in Stem Cell Therapy"],"prefix":"10.1007","author":[{"given":"Silvia","family":"P\u00e9rez L\u00f3pez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Otero Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"19_CR1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1172\/JCI40543","volume":"120","author":"O Lindvall","year":"2010","unstructured":"Lindvall O, Kokaia Z. Stem cells in human neurodegenerative disorders\u2014time for clinical translation? J Clin Invest 2010; 120:29\u201340.","journal-title":"J Clin Invest"},{"key":"19_CR2","unstructured":"ISSCR Task Force for the Clinical Translation of Stem Cells. Guidelines for the Clinical Translation of Stem Cells. Available in http:\/\/isscr.org."},{"key":"19_CR3","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1602\/neurorx.1.4.382","volume":"1","author":"O Lindvall","year":"2004","unstructured":"Lindvall O, Bj\u00f6rklund A. Cell therapy in Parkinson\u2019s disease. NeuroRx 2004; 1:382\u2013393.","journal-title":"NeuroRx"},{"key":"19_CR4","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/16060","volume":"2","author":"P Piccini","year":"1999","unstructured":"Piccini P, Brooks DJ, Bj\u00f6rklund A et al. Dopamine release from nigral transplants visualized in vivo in a Parkinson\u2019s patient. Nat Neurosci 1999; 2:1137\u20131140.","journal-title":"Nat Neurosci"},{"key":"19_CR5","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1002\/ana.10720","volume":"54","author":"CW Olanow","year":"2003","unstructured":"Olanow CW, Goetz CG, Kordower JH et al. A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson\u2019s disease. Ann Neurol 2003; 54:403\u2013414.","journal-title":"Ann Neurol"},{"key":"19_CR6","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1056\/NEJM200103083441002","volume":"344","author":"CR Freed","year":"2001","unstructured":"Freed CR, Greene PE, Breeze RE et al. Transplantation of embryonic dopamine neurons for severe Parkinson\u2019s disease. N Engl J Med 2001; 344:710\u2013719.","journal-title":"N Engl J Med"},{"key":"19_CR7","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nn863","volume":"5","author":"P Hagell","year":"2002","unstructured":"Hagell P, Piccini P, Bj\u00f6rklund A et al. Dyskinesias following neural transplantation in Parkinson\u2019s disease. Nat Neurosci 2002; 5:627\u2013628.","journal-title":"Nat Neurosci"},{"key":"19_CR8","doi-asserted-by":"publisher","first-page":"3392","DOI":"10.1073\/pnas.0712359105","volume":"105","author":"MS Cho","year":"2008","unstructured":"Cho MS, Lee YE, Kim JY et al. Highly efficient and large-scale generation of functional dopamine neurons from human embryonic stem cells. Proc Natl Acad Sci USA 2008; 105:3392\u20133397.","journal-title":"Proc Natl Acad Sci USA"},{"key":"19_CR9","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1172\/JCI200420935","volume":"113","author":"M Dezawa","year":"2004","unstructured":"Dezawa M, Kanno H, Hoshino M et al. Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. J Clin Invest 2004; 113:1701\u20131710.","journal-title":"J Clin Invest"},{"key":"19_CR10","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s12033-009-9166-8","volume":"42","author":"KK Jain","year":"2009","unstructured":"Jain KK. Cell therapy for CNS trauma. Mol Biotechnol 2009; 42:367\u2013376.","journal-title":"Mol Biotechnol"},{"key":"19_CR11","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1002\/jnr.22054","volume":"87","author":"SU Kim","year":"2009","unstructured":"Kim SU, de Vellis J. Stem cell-based cell therapy in neurological diseases: a review. J Neurosci Res 2009; 87:2183\u20132200.","journal-title":"J Neurosci Res"},{"key":"19_CR12","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1179\/174313208X284070","volume":"30","author":"J Louro","year":"2008","unstructured":"Louro J, Pearse DD. Stem and progenitor cell therapies: recent progress for spinal cord injury repair. Neurol Res 2008; 30:5\u201316.","journal-title":"Neurol Res"},{"key":"19_CR13","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.3727\/096368908787648074","volume":"17","author":"LF Geffner","year":"2008","unstructured":"Geffner LF, Santacruz P, Izurieta M et al. Administration of autologous bone marrow stem cells into spinal cord injury patients via multiple routes is safe and improves their quality of life: comprehensive case studies. Cell Transplant 2008; 17:1277\u20131293.","journal-title":"Cell Transplant"},{"key":"19_CR14","first-page":"241","volume":"7","author":"AA Kumar","year":"2009","unstructured":"Kumar AA, Kumar SR, Narayanan R et al. Autologous bone marrow derived mononuclear cell therapy for spinal cord injury: a phase I\/II clinical safety and primary efficacy data. Exp Clin Transplant 2009; 7:241\u2013248.","journal-title":"Exp Clin Transplant"},{"key":"19_CR15","doi-asserted-by":"publisher","first-page":"1931","DOI":"10.1634\/stemcells.2007-0097","volume":"25","author":"H Lee","year":"2007","unstructured":"Lee H, Shamy GA, Elkabetz Y et al. Directed differentiation and transplantation of human embryonic stem cell-derived motoneurons. Stem Cells 2007; 25:1931\u20131939.","journal-title":"Stem Cells"},{"key":"19_CR16","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/jnr.21856","volume":"87","author":"PM Jordan","year":"2009","unstructured":"Jordan PM, Ojeda LD, Thonhoff JR et al. Generation of spinal motor neurons from human fetal brain-derived neural stem cells: role of basic fibroblast growth factor. J Neurosci Res 2009; 87:318\u2013332.","journal-title":"J Neurosci Res"},{"key":"19_CR17","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1212\/01.wnl.0000327668.43541.22","volume":"71","author":"SH Appel","year":"2008","unstructured":"Appel SH, Engelhardt JI, Henkel JS et al. Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis. Neurology. 2008; 71:1326\u20131334.","journal-title":"Neurology"},{"key":"19_CR18","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.jns.2007.05.016","volume":"265","author":"L Mazzini","year":"2008","unstructured":"Mazzini L, Mareschi K, Ferrero I et al. Stem cell treatment in amyotrophic lateral sclerosis. J Neurol Sci 2008; 265:78\u201383.","journal-title":"J Neurol Sci"},{"key":"19_CR19","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.expneurol.2009.08.007","volume":"223","author":"L Mazzini","year":"2010","unstructured":"Mazzini L, Ferrero I, Luparello V et al. Mesenchymal stem cell transplantation in amyotrophic lateral sclerosis: a phase I clinical trial. Exp Neurol 2010; 223:229\u2013237.","journal-title":"Exp Neurol"},{"key":"19_CR20","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1080\/14653240802549470","volume":"11","author":"H Deda","year":"2009","unstructured":"Deda H, Inci MC, K\u00fcrek\u00e7i AE et al. Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up. Cytotherapy 2009; 11:18\u201325.","journal-title":"Cytotherapy"},{"key":"19_CR21","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1097\/nen.0b013e318160c5db","volume":"67","author":"B Li","year":"2008","unstructured":"Li B, Yamamori H, Tatebayashi Y et al. Failure of neuronal maturation in Alzheimer disease dentate gyrus. J Neuropathol Exp Neurol 2008; 67:78\u201384.","journal-title":"J Neuropathol Exp Neurol"},{"key":"19_CR22","doi-asserted-by":"crossref","first-page":"3604","DOI":"10.1523\/JNEUROSCI.10-11-03604.1990","volume":"10","author":"MH Tuszynski","year":"1990","unstructured":"Tuszynski MH, U HS, Amaral DG et al. Nerve growth factor infusion in primate brain reduces lesion-induced cholinergic neuronal degeneration. J Neurosci 1990; 10:3604\u20133614.","journal-title":"J Neurosci"},{"key":"19_CR23","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nm1239","volume":"11","author":"MH Tuszynski","year":"2005","unstructured":"Tuszynski MH, Thal L, Pay M et al. A phase I clinical trial of nerve growth factor gene therapy for Alzheimer disease. Nat Med 2005; 11:551\u2013555.","journal-title":"Nat Med"},{"key":"19_CR24","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1212\/WNL.55.4.565","volume":"55","author":"D Kondziolka","year":"2000","unstructured":"Kondziolka D, Wechsler L, Goldstein S et al. Transplantation of cultured human neuronal cells for patients with stroke. Neurology 2000; 55:565\u2013569.","journal-title":"Neurology"},{"key":"19_CR25","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3171\/jns.2005.103.1.0038","volume":"103","author":"D Kondziolka","year":"2005","unstructured":"Kondziolka D, Steinberg GK, Wechsler L et al. Neurotransplantation for patients with subcortical motor stroke: a phase 2 randomized trial. J Neurosurg 2005; 103:38\u201345.","journal-title":"J Neurosurg"},{"key":"19_CR26","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1002\/ana.20501","volume":"57","author":"OY Bang","year":"2005","unstructured":"Bang OY, Lee JS, Lee PH et al. Autologous mesenchymal stem cell transplantation in stroke patients. Ann Neurol 2005; 57:874\u2013882.","journal-title":"Ann Neurol"},{"key":"19_CR27","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1083\/jcb.9.2.493","volume":"9","author":"A Mauro","year":"1961","unstructured":"Mauro A. Satellite cell of skeletal muscle fibers. J Biophys Biochem Cytol 1961; 9:493\u2013495.","journal-title":"J Biophys Biochem Cytol"},{"key":"19_CR28","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/0140-6736(90)91628-N","volume":"336","author":"PK Law","year":"1990","unstructured":"Law PK, Bertorini TE, Goodwin TG et al. Dystrophin production induced by myoblast transfer therapy in Duchenne muscular dystrophy. Lancet 1990; 336:114\u2013115.","journal-title":"Lancet"},{"key":"19_CR29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1172\/JCI40373","volume":"120","author":"FS Tedesco","year":"2010","unstructured":"Tedesco FS, Dellavalle A, Diaz-Manera J et al. Repairing skeletal muscle: regenerative potential of skeletal muscle stem cells. J Clin Invest 2010; 120:11\u201319.","journal-title":"J Clin Invest"},{"key":"19_CR30","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.molmed.2007.10.003","volume":"13","author":"G Cossu","year":"2007","unstructured":"Cossu G, Sampaolesi M. New therapies for Duchenne muscular dystrophy: challenges, prospects and clinical trials. Trends Mol Med 2007; 13:520\u2013526.","journal-title":"Trends Mol Med"},{"key":"19_CR31","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1002\/(SICI)1097-4598(199607)19:7<853::AID-MUS7>3.0.CO;2-8","volume":"19","author":"Y Fan","year":"1996","unstructured":"Fan Y, Maley M, Beilharz M et al. Rapid death of injected myoblasts in myoblast transfer therapy. Muscle Nerve 1996; 19:853\u2013860.","journal-title":"Muscle Nerve"},{"key":"19_CR32","doi-asserted-by":"publisher","first-page":"659","DOI":"10.3727\/000000006783981648","volume":"15","author":"D Skuk","year":"2006","unstructured":"Skuk D, Goulet M, Tremblay JP. Use of repeating dispensers to increase the efficiency of the intramuscular myogenic cell injection procedure. Cell Transplant 2006; 15:659\u2013663.","journal-title":"Cell Transplant"},{"key":"19_CR33","doi-asserted-by":"crossref","first-page":"563","DOI":"10.3727\/000000007783465064","volume":"16","author":"Y Torrente","year":"2007","unstructured":"Torrente Y, Belicchi M, Marchesi C et al. Autologous transplantation of muscle-derived CD133 + stem cells in Duchenne muscle patients. Cell Transplant 2007; 16:563\u2013577.","journal-title":"Cell Transplant"},{"key":"19_CR34","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1007\/s00192-007-0553-z","volume":"19","author":"LK Carr","year":"2008","unstructured":"Carr LK, Steele D, Steele S et al. 1-year follow-up of autologous muscle-derived stem cell injection pilot study to treat stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct 2008; 19:881\u2013883.","journal-title":"Int Urogynecol J Pelvic Floor Dysfunct"},{"key":"19_CR35","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/s00345-007-0190-7","volume":"25","author":"H Strasser","year":"2007","unstructured":"Strasser H, Marksteiner R, Margreiter E et al. Transurethral ultrasonography-guided injection of adult autologous stem cells versus transurethral endoscopic injection of collagen in treatment of urinary incontinence. World J Urol 2007; 25:385\u2013392.","journal-title":"World J Urol"},{"key":"19_CR36","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.eururo.2007.07.026","volume":"53","author":"M Mitterberger","year":"2008","unstructured":"Mitterberger M, Pinggera GM, Marksteiner R et al. Adult stem cell therapy of female stress urinary incontinence. Eur Urol 2008; 53:169\u2013175.","journal-title":"Eur Urol"},{"key":"19_CR37","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1073\/pnas.0406266102","volume":"102","author":"G Wang","year":"2005","unstructured":"Wang G, Bunnell BA, Painter RG et al. Adult stem cells from bone marrow stroma differentiate into airway epithelial cells: potential therapy for cystic fibrosis. Proc Natl Acad Sci U S A 2005; 102:186\u2013191.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"19_CR38","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.cell.2005.03.032","volume":"121","author":"CF Kim","year":"2005","unstructured":"Kim CF, Jackson EL, Woolfenden AE et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell 2005; 121:823\u2013835.","journal-title":"Cell"},{"key":"19_CR39","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1161\/01.RES.0000157672.70560.7b","volume":"96","author":"YD Zhao","year":"2005","unstructured":"Zhao YD, Courtman DW, Deng Y et al. Rescue of monocrotaline-induced pulmonary arterial hypertension using bone marrow-derived endothelial-like progenitor cells: efficacy of combined cell and eNOS gene therapy in established disease. Circ Res 2005; 96:442\u2013450.","journal-title":"Circ Res"},{"key":"19_CR40","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1089\/1076327041348563","volume":"10","author":"M Takahashi","year":"2004","unstructured":"Takahashi M, Nakamura T, Toba T et al. Transplantation of endothelial progenitor cells into the lung to alleviate pulmonary hypertension in dogs. Tissue Eng 2004; 10:771\u2013779.","journal-title":"Tissue Eng"},{"key":"19_CR41","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.jacc.2006.12.037","volume":"49","author":"XX Wang","year":"2007","unstructured":"Wang XX, Zhang FR, Shang YP et al. Transplantation of autologous endothelial progenitor cells may be beneficial in patients with idiopathic pulmonary arterial hypertension: a pilot randomized controlled trial. J Am Coll Cardiol 2007; 49:1566\u20131571.","journal-title":"J Am Coll Cardiol"},{"key":"19_CR42","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1053\/jhep.2001.21900","volume":"33","author":"S Sell","year":"2001","unstructured":"Sell S. Heterogeneity and plasticity of hepatocyte lineage cells. Hepatology 2001; 33:738\u2013750.","journal-title":"Hepatology"},{"key":"19_CR43","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s10545-006-0245-8","volume":"29","author":"A Dhawan","year":"2006","unstructured":"Dhawan A, Mitry RR, Hughes RD. Hepatocyte transplantation for liver-based metabolic disorders. J Inherit Metab Dis 2006; 29:431\u2013435.","journal-title":"J Inherit Metab Dis"},{"key":"19_CR44","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/S1084952102001271","volume":"13","author":"SH Oh","year":"2002","unstructured":"Oh SH, Hatch HM, Petersen BE. Hepatic oval\u2019 stem\u2019 cell in liver regeneration. Semin Cell Dev Biol 2002; 13:405\u2013409.","journal-title":"Semin Cell Dev Biol"},{"key":"19_CR45","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1016\/j.yexcr.2009.02.004","volume":"315","author":"JD Terrace","year":"2009","unstructured":"Terrace JD, Hay DC, Samuel K et al. Side population cells in developing human liver are primarily haematopoietic progenitor cells. Exp Cell Res 2009; 315:2141\u20132153.","journal-title":"Exp Cell Res"},{"key":"19_CR46","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/81326","volume":"6","author":"E Lagasse","year":"2000","unstructured":"Lagasse E, Connors H, Al-Dhalimy M et al. Purified hematopoietic stem cells can differentiate into hepatocytes in vivo. Nat Med 2000; 6:1229\u20131234.","journal-title":"Nat Med"},{"key":"19_CR47","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1053\/j.gastro.2008.05.040","volume":"135","author":"DD Houlihan","year":"2008","unstructured":"Houlihan DD, Newsome PN. Critical review of clinical trials of bone marrow stem cells in liver disease. Gastroenterology 2008; 135:438\u2013450.","journal-title":"Gastroenterology"},{"key":"19_CR48","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1002\/hep.21704","volume":"46","author":"A Banas","year":"2007","unstructured":"Banas A, Teratani T, Yamamoto Y et al. Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes. Hepatology 2007; 46:219\u2013228.","journal-title":"Hepatology"},{"key":"19_CR49","doi-asserted-by":"publisher","first-page":"139","DOI":"10.2174\/157488806776956878","volume":"1","author":"K Asahina","year":"2006","unstructured":"Asahina K, Teramoto K, Teraoka H. Embryonic stem cells: hepatic differentiation and regenerative medicine for the treatment of liver disease. Curr Stem Cell Res Ther 2006; 1:139\u2013156.","journal-title":"Curr Stem Cell Res Ther"},{"key":"19_CR50","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1097\/MEG.0b013e32832a1f6c","volume":"21","author":"P Kharaziha","year":"2009","unstructured":"Kharaziha P, Hellstr\u00f6m PM, Noorinayer B et al. Improvement of liver function in liver cirrhosis patients after autologous mesenchymal stem cell injection: a phase I\u2013II clinical trial. Eur J Gastroenterol Hepatol 2009; 21:1199\u20131205.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"19_CR51","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.3748\/wjg.v13.i7.1067","volume":"13","author":"AC Lyra","year":"2007","unstructured":"Lyra AC, Soares MB, da Silva LF et al. Feasibility and safety of autologous bone marrow mononuclear cell transplantation in patients with advanced chronic liver disease. World J Gastroenterol 2007; 13:1067\u20131073.","journal-title":"World J Gastroenterol"},{"key":"19_CR52","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1097\/MEG.0b013e32832eb69a","volume":"22","author":"AC Lyra","year":"2010","unstructured":"Lyra AC, Soares MB, da Silva LF et al. Infusion of autologous bone marrow mononuclear cells through hepatic artery results in a short-term improvement of liver function in patients with chronic liver disease: a pilot randomized controlled study. Eur J Gastroenterol Hepatol 2010; 22:33\u201342.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"Suppl 1","key":"19_CR53","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-2184.2008.00491.x","volume":"41","author":"N Levicar","year":"2008","unstructured":"Levicar N, Pai M, Habib NA et al. Long-term clinical results of autologous infusion of mobilized adult bone marrow derived CD34+ cells in patients with chronic liver disease. Cell Prolif 2008; 41 Suppl 1:115\u2013125.","journal-title":"Cell Prolif"},{"key":"19_CR54","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1016\/j.exphem.2006.06.012","volume":"34","author":"E Yannaki","year":"2006","unstructured":"Yannaki E, Anagnostopoulos A, Kapetanos D et al. Lasting amelioration in the clinical course of decompensated alcoholic cirrhosis with boost infusions of mobilized peripheral blood stem cells. Exp Hematol 2006; 34:1583\u20131587.","journal-title":"Exp Hematol"},{"key":"19_CR55","doi-asserted-by":"publisher","first-page":"575","DOI":"10.2217\/17460751.3.4.575","volume":"3","author":"JC Gerlach","year":"2008","unstructured":"Gerlach JC, Zeilinger K, Patzer II JF. Bioartificial liver systems: why, what, whither? Regen Med 2008; 3:575\u2013595.","journal-title":"Regen Med"},{"issue":"2","key":"19_CR56","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1055\/s-2008-1073120","volume":"28","author":"TJ McKenzie","year":"2008","unstructured":"McKenzie TJ, Lillegard JB, Nyberg SL. Artificial and bioartificial liver support. Semin Liver Dis 2008; 28(2):210\u2013217.","journal-title":"Semin Liver Dis"},{"key":"19_CR57","doi-asserted-by":"publisher","first-page":"1750","DOI":"10.1056\/NEJM200106073442303","volume":"344","author":"AP Beltrami","year":"2001","unstructured":"Beltrami AP, Urbanek K, Kajstura J et al. Evidence that human cardiac myocytes divide alter myocardial infarction. N Engl J Med 2001; 344:1750\u20131757.","journal-title":"N Engl J Med"},{"key":"19_CR58","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1126\/science.1164680","volume":"324","author":"O Bergmann","year":"2009","unstructured":"Bergmann O, Bhardwaj RD, Bernard S et al. Evidence for cardiomyocyte renewal in humans. Science 2009; 324:47\u201348.","journal-title":"Science"},{"key":"19_CR59","first-page":"186","volume":"51","author":"PP Rumyantsev","year":"1977","unstructured":"Rumyantsev PP. Interrelations of the proliferation and differentiation processes during cardiac myogenesis and regeneration. Int Rev Cytol 1977; 51:186\u2013273.","journal-title":"Int Rev Cytol"},{"key":"19_CR60","unstructured":"Soonpaa MH, Field LJ. Survey of studies examining mammalian cardiomyocyte DNA synthesis. Circ Res 1998; 8315\u20138326."},{"key":"19_CR61","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1016\/S0300-8932(09)72101-3","volume":"62","author":"DA Taylor","year":"2009","unstructured":"Taylor DA, Robertson MJ. The basics of cell therapy to treat cardiovascular disease: one cell does not fit all. Rev Esp Cardiol 2009; 62:1032\u20131044.","journal-title":"Rev Esp Cardiol"},{"key":"19_CR62","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1161\/CIRCULATIONAHA.106.655209","volume":"115","author":"RR Smith","year":"2007","unstructured":"Smith RR, Barile L, Cho HC et al. Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens. Circulation 2007; 115:896\u2013908.","journal-title":"Circulation"},{"key":"19_CR63","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1056\/NEJMoa043814","volume":"353","author":"N Werner","year":"2005","unstructured":"Werner N, Kosiol S, Schiegl T et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005; 353:999\u20131007.","journal-title":"N Engl J Med"},{"key":"19_CR64","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1126\/science.284.5411.143","volume":"284","author":"MF Pittenger","year":"1999","unstructured":"Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999; 284:143\u2013147.","journal-title":"Science"},{"key":"19_CR65","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1001\/archinte.167.10.989","volume":"167","author":"A Abdel-Latif","year":"2007","unstructured":"Abdel-Latif A, Bolli R, Tleyjeh IM et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med 2007; 167:989\u2013997.","journal-title":"Arch Intern Med"},{"key":"19_CR66","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1111\/j.1582-4934.2006.tb00432.x","volume":"10","author":"M Hristov","year":"2006","unstructured":"Hristov M, Heussen N, Schober A et al. Intracoronary infusion of autologous bone marrow cells and left ventricular function after acute myocardial infarction: a meta-analysis. J Cell Mol Med 2006; 10:727\u2013733.","journal-title":"J Cell Mol Med"},{"key":"19_CR67","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/j.jacc.2007.07.041","volume":"50","author":"MJ Lipinski","year":"2007","unstructured":"Lipinski MJ, Biondi-Zoccai GG, Abbate A et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol 2007; 50:1761\u20131767.","journal-title":"J Am Coll Cardiol"},{"key":"19_CR68","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1056\/NEJMoa055706","volume":"355","author":"K Lunde","year":"2006","unstructured":"Lunde K, Solheim S, Aakhus S et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med 2006; 355:1199\u20131209.","journal-title":"N Engl J Med"},{"key":"19_CR69","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/35070587","volume":"410","author":"D Orlic","year":"2001","unstructured":"Orlic D, Kajstura J, Chimenti S et al. Bone marrow cells regenerate infarcted myocardium. Nature 2001; 410:701\u2013705.","journal-title":"Nature"},{"key":"19_CR70","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1038\/nature02460","volume":"428","author":"LB Balsam","year":"2004","unstructured":"Balsam LB, Wagers AJ, Christensen JL et al. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 2004; 428:668\u2013673.","journal-title":"Nature"},{"key":"19_CR71","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1038\/nature02069","volume":"425","author":"M Alvarez-Dolado","year":"2003","unstructured":"Alvarez-Dolado M, Pardal R, Garcia-Verdugo JM et al. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 2003; 425:968\u2013973.","journal-title":"Nature"},{"key":"19_CR72","doi-asserted-by":"publisher","first-page":"2851","DOI":"10.1093\/eurheartj\/ehn456","volume":"29","author":"M Korf-Klingebiel","year":"2008","unstructured":"Korf-Klingebiel M, Kempf T, Sauer T et al. Bone marrow cells are a rich source of growth factors and cytokines: implications for cell therapy trials after myocardial infarction. Eur Heart J 2008; 29:2851\u20132858.","journal-title":"Eur Heart J"},{"issue":"1 Suppl","key":"19_CR73","doi-asserted-by":"publisher","first-page":"S106","DOI":"10.1097\/01.CCM.0000296273.72952.39","volume":"36","author":"JW Petersen","year":"2008","unstructured":"Petersen JW, Felker GM. Inotropes in the management of acute heart failure. Crit Care Med 2008; 36 (1 Suppl):S106\u2013S111.","journal-title":"Crit Care Med"},{"key":"19_CR74","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1038\/nature06800","volume":"451","author":"VF Segers","year":"2008","unstructured":"Segers VF, Lee RT. Stem-cell therapy for cardiac disease. Nature 2008; 451:937\u2013942.","journal-title":"Nature"},{"key":"19_CR75","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/356435a0","volume":"356","author":"E Gussoni","year":"1992","unstructured":"Gussoni E, Pavlath GK, Lanctot AM et al. Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation. Nature 1992; 356:435\u2013438.","journal-title":"Nature"},{"key":"19_CR76","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1002\/ana.410340105","volume":"34","author":"G Karpati","year":"1993","unstructured":"Karpati G, Ajdukovic D, Arnold D et al. Myoblast transfer in Duchenne muscular dystrophy. Ann Neurol 1993; 34:8\u201317.","journal-title":"Ann Neurol"},{"key":"19_CR77","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/(SICI)1097-4598(199803)21:3<291::AID-MUS2>3.0.CO;2-5","volume":"21","author":"H Ito","year":"1998","unstructured":"Ito H, Hallauer PL, Hastings KE et al. Prior culture with concanavalin A increases intramuscular migration of transplanted myoblast. Muscle Nerve 1998; 21:291\u2013297.","journal-title":"Muscle Nerve"},{"key":"19_CR78","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/mus.880180107","volume":"18","author":"B Gu\u00e9rette","year":"1995","unstructured":"Gu\u00e9rette B, Asselin I, Vilquin JT et al. Lymphocyte infiltration following allo-and xenomyoblast transplantation in mdx mice. Muscle Nerve 1995; 18:39\u201351.","journal-title":"Muscle Nerve"},{"key":"19_CR79","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/86498","volume":"7","author":"AA Kocher","year":"2001","unstructured":"Kocher AA, Schuster MD, Szabolcs MJ et al. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat Med 2001; 7:430\u2013436.","journal-title":"Nat Med"},{"key":"19_CR80","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1161\/01.CIR.0000124062.31102.57","volume":"109","author":"T Kinnaird","year":"2004","unstructured":"Kinnaird T, Stabile E, Burnett MS et al. Local delivery of marrow-derived stromal cells augments collateral perfusion through paracrine mechanisms. Circulation 2004; 109:1543\u20131549.","journal-title":"Circulation"},{"key":"19_CR81","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/nm1684","volume":"14","author":"HC Ott","year":"2008","unstructured":"Ott HC, Matthiesen TS, Goh SK et al. Perfusion-decellularized matrix: using nature\u2019s platform to engineer a bioartificial heart. Nat Med 2008; 14:213\u2013221.","journal-title":"Nat Med"},{"key":"19_CR82","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1016\/j.copbio.2009.10.016","volume":"20","author":"DA Taylor","year":"2009","unstructured":"Taylor, DA. From stem cells and cadaveric matrix to engineered organs. Curr Opin Biotechnol 2009; 20:598\u2013605.","journal-title":"Curr Opin Biotechnol"},{"key":"19_CR83","doi-asserted-by":"publisher","first-page":"2775","DOI":"10.1093\/eurheartj\/ehl388","volume":"27","author":"V Sch\u00e4chinger","year":"2006","unstructured":"Sch\u00e4chinger V, Erbs S, Els\u00e4sser A et al. Improved clinical outcome after intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J 2006; 27:2775\u20132783.","journal-title":"Eur Heart J"},{"key":"19_CR84","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1161\/CIRCULATIONAHA.107.734103","volume":"117","author":"P Menasch\u00e9","year":"2008","unstructured":"Menasch\u00e9 P, Alfieri O, Janssens S et al. The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation. Circulation 2008; 117:1189\u20131200.","journal-title":"Circulation"},{"key":"19_CR85","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jcin.2008.11.003","volume":"2","author":"N Dib","year":"2009","unstructured":"Dib N, Dinsmore J, Lababidi Z et al. One-year follow-up of feasibility and safety of the first US, randomized, controlled study using 3-dimensional guided catheter-based delivery of autologous skeletal myoblasts for ischemic cardiomyopathy (CAuSMIC study). JAC Cardiovasc Interv 2009; 2:9\u201316.","journal-title":"JAC Cardiovasc Interv"},{"key":"19_CR86","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1681\/ASN.2007080895","volume":"19","author":"J Tumlin","year":"2008","unstructured":"Tumlin J, Wali R, Williams W et al. Efficacy and safety of renal tubule cell therapy for acute renal failure. J Am Soc Nephrol 2008; 19:1034\u20131040.","journal-title":"J Am Soc Nephrol"},{"key":"19_CR87","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1001\/jama.297.14.1568","volume":"297","author":"JC Voltarelli","year":"2007","unstructured":"Voltarelli JC, Couri CE, Stracieri AB et al. Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus. JAMA 2007; 297:1568\u20131576.","journal-title":"JAMA"},{"key":"19_CR88","first-page":"49","volume":"49","author":"JD Hooi","year":"1999","unstructured":"Hooi JD, Stoffers HE, Knottnerus JA et al. The prognosis of noncritical limb ischaemia: a systematic review of population-based evidence. Br J Gen Pract 1999; 49:49\u201355.","journal-title":"Br J Gen Pract"},{"key":"19_CR89","first-page":"138","volume":"12","author":"J Dormandy","year":"1999","unstructured":"Dormandy J, Heeck L, Vig S. Predicting which patients will develop chronic critical leg ischemia. Semin Vasc Surg 1999; 12:138\u2013141.","journal-title":"Semin Vasc Surg"},{"key":"19_CR90","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1148\/radiology.177.3.2147067","volume":"177","author":"Guidelines for Percutaneous Transluminal Angioplasty","year":"1990","unstructured":"Guidelines for Percutaneous Transluminal Angioplasty. Standards of practice committee of the society of cardiovascular and interventional radiology. Radiology 1990; 177:619\u2013626.","journal-title":"Radiology"},{"issue":"21","key":"19_CR91","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1056\/NEJM200105243442108","volume":"344","author":"WR Hiatt","year":"2001","unstructured":"Hiatt WR. Medical treatment of peripheral arterial disease and claudication. N Engl J Med 2001; 344(21):1608\u20131621.","journal-title":"N Engl J Med"},{"key":"19_CR92","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/SLA.0b013e318153fdcb","volume":"247","author":"RW Sprengers","year":"2008","unstructured":"Sprengers RW, Lips DJ, Moll FL et al. Progenitor cell therapy in patients with critical limb ischemia without surgical options. Ann Surg 2008; 247:411\u2013420.","journal-title":"Ann Surg"},{"key":"19_CR93","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1002\/stem.207","volume":"27","author":"A Kawamoto","year":"2009","unstructured":"Kawamoto A, Katayama M, Handa N et al. Intramuscular transplantation of G-CSF-mobilized CD34(+) cells in patients with critical limb ischemia: a phase I\/IIa, multicenter, single-blinded, dose-escalation clinical trial. Stem Cells 2009; 27:2857\u20132864.","journal-title":"Stem Cells"},{"key":"19_CR94","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/modpathol.2008.48","volume":"21","author":"JP Duong Van Huyen","year":"2008","unstructured":"Duong Van Huyen JP, Smadja DM, Bruneval P et al. Bone marrow-derived mononuclear cell therapy induces distal angiogenesis after local injection in critical leg ischemia. Mod Pathol 2008; 21:837\u2013846.","journal-title":"Mod Pathol"},{"key":"19_CR95","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/00006534-200201000-00030","volume":"109","author":"H Mizuno","year":"2002","unstructured":"Mizuno H, Zuk PA, Zhu M et al. Myogenic differentiation by human processed lipoaspirate cells. Plast Reconstr Surg 2002; 109:199\u2013209.","journal-title":"Plast Reconstr Surg"},{"key":"19_CR96","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/s00384-003-0490-3","volume":"18","author":"D Garc\u00eda-Olmo","year":"2003","unstructured":"Garc\u00eda-Olmo D, Garc\u00eda-Arranz M, Garc\u00eda LG et al. Autologous stem cell transplantation for treatment of rectovaginal fistula in perianal Crohn\u2019s disease: a new cell-based therapy. Int J Colorectal Dis 2003; 18:451\u2013454.","journal-title":"Int J Colorectal Dis"},{"key":"19_CR97","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1007\/s10350-005-0052-6","volume":"48","author":"D Garc\u00eda-Olmo","year":"2005","unstructured":"Garc\u00eda-Olmo D, Garc\u00eda-Arranz M, Herreros D et al. A phase I clinical trial of the treatment of Crohn\u2019s fistula by adipose mesenchymal stem cell transplantation. Dis Colon Rectum 2005; 48:1416\u20131423.","journal-title":"Dis Colon Rectum"},{"key":"19_CR98","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/sc.1996.46","volume":"345","author":"DW Byrne","year":"1996","unstructured":"Byrne DW, Salzberg CA. Major risk factors for pressure ulcers in spinal cord disabled: a literature review. Spinal cord 1996; 345:255\u2013263.","journal-title":"Spinal cord"},{"key":"19_CR99","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1634\/stemcells.22-5-812","volume":"225","author":"C Fathke","year":"2004","unstructured":"Fathke C, Wilson L, Hutter J et al. Contribution of bone marrow-derived cells to skin: collagen deposition and wound repair. Stem Cells 2004; 225:812\u2013822.","journal-title":"Stem Cells"},{"key":"19_CR100","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1089\/ten.2005.11.110","volume":"111\u2013112","author":"W Deng","year":"2005","unstructured":"Deng W, Han Q, Liao L et al. Engrafted bone marrow-derived flk-1+ mesenchymal stem cells regenerate skin tissue. Tissue Eng 2005; 111\u2013112:110\u2013119.","journal-title":"Tissue Eng"},{"key":"19_CR101","doi-asserted-by":"publisher","first-page":"2647","DOI":"10.1001\/jama.2008.778","volume":"300","author":"M Reddy","year":"2008","unstructured":"Reddy M, Gill SS, Kalkar SR et al. Treatment of pressure ulcers: a systematic review. JAMA 2008; 300:2647\u20132462.","journal-title":"JAMA"}],"container-title":["Advances in Experimental Medicine and Biology","Stem Cell Transplantation"],"original-title":[],"link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4614-2098-9_19.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T04:07:50Z","timestamp":1713758870000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4614-2098-9_19"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012]]},"ISBN":["9781461420972","9781461420989"],"references-count":101,"URL":"https:\/\/doi.org\/10.1007\/978-1-4614-2098-9_19","relation":{"is-part-of":[{"id-type":"doi","id":"https:\/\/doi.org\/10.1007\/978-1-4614-2098-9","asserted-by":"object"}]},"ISSN":["0065-2598"],"issn-type":[{"value":"0065-2598","type":"print"}],"subject":[],"published":{"date-parts":[[2012]]}}}